Tiedemann Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,871
Closed -$454K 340
2020
Q4
$454K Buy
3,871
+1,388
+56% +$153K 0.02% 211
2020
Q3
$259K Buy
+2,483
New +$249K 0.01% 274
2020
Q1
Sell
-2,610
Closed -$297K 312
2019
Q4
$297K Sell
2,610
-372
-12% -$40.8K 0.01% 247
2019
Q3
$326K Sell
2,982
-387
-11% -$40.4K 0.02% 251
2019
Q2
$327K Sell
3,369
-7,689
-70% -$702K 0.02% 234
2019
Q1
$1.01M Buy
11,058
+360
+3% +$32.2K 0.05% 215
2018
Q4
$979K Buy
10,698
+8,456
+377% +$790K 0.05% 212
2018
Q3
$221K Sell
2,242
-150
-6% -$13.9K 0.01% 291
2018
Q2
$204K Buy
+2,392
New +$200K 0.01% 285
2017
Q4
Sell
-24,966
Closed -$2.15M 290
2017
Q3
$2.15M Sell
24,966
-11,233
-31% -$933K 0.19% 91
2017
Q2
$3.21M Buy
36,199
+3,460
+11% +$292K 0.23% 85
2017
Q1
$2.64M Buy
32,739
+8,593
+36% +$671K 0.22% 94
2016
Q4
$1.72M Buy
+24,146
New +$1.9M 0.17% 103

Other funds holding MDT

Tiedemann Advisors's MDT Position: Q1 2021 in Review

Tiedemann Advisors sold out of Medtronic (MDT) in Q1 2021, closing a stake of 3,871 shares — an estimated $454K sold.

Tiedemann Advisors first reported a position in MDT in Q4 2016 and held it in 13 quarters. The position peaked at $3.21M in Q2 2017. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • Tiedemann Advisors reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • Tiedemann Advisors sold 3,871 Medtronic shares in Q1 2021, an estimated $454K.
  • Tiedemann Advisors first reported a position in Medtronic in Q4 2016 and held it in 13 quarters.
  • Tiedemann Advisors's Medtronic position peaked at $3.21M in Q2 2017.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Tiedemann Advisors's 13F filing for Q1 2021, filed 13 May 2021.